skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: assunto: Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Clonal chromosomal abnormalities in CD34 CD38 hematopoietic cells from cytogenetically normal chronic myeloid leukemia patients with a complete cytogenetic response to tyrosine kinase inhibitors
Clonal chromosomal abnormalities in CD34 CD38 hematopoietic cells from cytogenetically normal chronic myeloid leukemia patients with a complete cytogenetic response to tyrosine kinase inhibitors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clonal chromosomal abnormalities in CD34 CD38 hematopoietic cells from cytogenetically normal chronic myeloid leukemia patients with a complete cytogenetic response to tyrosine kinase inhibitors

BUMM, T ; DEININGER, J ; NEWELL, A. H ; LAWCE, H ; OLSON, S ; MAURO, M ; DRUKER, B ; DEININGER, M

Leukemia, 2010-08, Vol.24 (8), p.1525-1528 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
High-throughput mutational screen of the tyrosine kinome in chronic myelomonocytic leukemia
High-throughput mutational screen of the tyrosine kinome in chronic myelomonocytic leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

High-throughput mutational screen of the tyrosine kinome in chronic myelomonocytic leukemia

Tyner, J W ; Loriaux, M M ; Erickson, H ; Eide, C A ; Deininger, J ; MacPartlin, M ; Willis, S G ; Lange, T ; Druker, B J ; Kovacsovics, T ; Maziarz, R ; Gattermann, N ; Deininger, M W

Leukemia, 2009-02, Vol.23 (2), p.406-409 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial
Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial

Verstovsek, Srdan ; Mesa, Ruben A ; Gotlib, Jason ; Gupta, Vikas ; DiPersio, John F ; Catalano, John V ; Deininger, Michael W N ; Miller, Carole B ; Silver, Richard T ; Talpaz, Moshe ; Winton, Elliott F ; Harvey, Jr, Jimmie H ; Arcasoy, Murat O ; Hexner, Elizabeth O ; Lyons, Roger M ; Paquette, Ronald ; Raza, Azra ; Jones, Mark ; Kornacki, Deanna ; Sun, Kang ; Kantarjian, Hagop

Journal of hematology and oncology, 2017-02, Vol.10 (1), p.55-14, Article 55 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
4
In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants
In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants
Material Type:
Artigo 		Adicionar ao Meu Espaço

In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants

O'HARE, Thomas ; WALTERS, Denise K ; DRUKER, Brian J ; STOFFREGEN, Eric P ; TAIPING JIA ; MANLEY, Paul W ; MESTAN, Jürgen ; COWAN-JACOB, Sandra W ; LEE, Francis Y ; HEINRICH, Michael C ; DEININGER, Michael W. N

Cancer research (Chicago, Ill.), 2005-06, Vol.65 (11), p.4500-4505 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
5
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial

Cortes, Jorge E ; Gambacorti-Passerini, Carlo ; Deininger, Michael W ; Mauro, Michael J ; Chuah, Charles ; Kim, Dong-Wook ; Dyagil, Irina ; Glushko, Nataliia ; Milojkovic, Dragana ; le Coutre, Philipp ; Garcia-Gutierrez, Valentin ; Reilly, Laurence ; Jeynes-Ellis, Allison ; Leip, Eric ; Bardy-Bouxin, Nathalie ; Hochhaus, Andreas ; Brümmendorf, Tim H

Journal of clinical oncology, 2018-01, Vol.36 (3), p.231-237 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
6
Tyrosine Kinase Inhibitor-Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia
Tyrosine Kinase Inhibitor-Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tyrosine Kinase Inhibitor-Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia

Moslehi, Javid J ; Deininger, Michael

Journal of clinical oncology, 2015-12, Vol.33 (35), p.4210-4218 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
7
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

Hochhaus, A ; Baccarani, M ; Silver, R T ; Schiffer, C ; Apperley, J F ; Cervantes, F ; Clark, R E ; Cortes, J E ; Deininger, M W ; Guilhot, F ; Hjorth-Hansen, H ; Hughes, T P ; Janssen, J J W M ; Kantarjian, H M ; Kim, D W ; Larson, R A ; Lipton, J H ; Mahon, F X ; Mayer, J ; Nicolini, F ; Niederwieser, D ; Pane, F ; Radich, J P ; Rea, D ; Richter, J ; Rosti, G ; Rousselot, P ; Saglio, G ; Saußele, S ; Soverini, S ; Steegmann, J L ; Turkina, A ; Zaritskey, A ; Hehlmann, R

Leukemia, 2020-04, Vol.34 (4), p.966-984 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Targeting the BCR-ABL Signaling Pathway in Therapy-Resistant Philadelphia Chromosome-Positive Leukemia
Targeting the BCR-ABL Signaling Pathway in Therapy-Resistant Philadelphia Chromosome-Positive Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Targeting the BCR-ABL Signaling Pathway in Therapy-Resistant Philadelphia Chromosome-Positive Leukemia

O'HARE, Thomas ; DEININGER, Michael W. N ; EIDE, Christopher A ; CLACKSON, Tim ; DRUKER, Brian J

Clinical cancer research, 2011-01, Vol.17 (2), p.212-221 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
9
Blockade of JAK2-mediated extrinsic survival signals restores sensitivity of CML cells to ABL inhibitors
Blockade of JAK2-mediated extrinsic survival signals restores sensitivity of CML cells to ABL inhibitors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Blockade of JAK2-mediated extrinsic survival signals restores sensitivity of CML cells to ABL inhibitors

TRAER, E ; MACKENZIE, R ; SNEAD, J ; AGARWAL, A ; EIRING, A. M ; O'HARE, T ; DRUKER, B. J ; DEININGER, M. W

Leukemia, 2012-05, Vol.26 (5), p.1140-1143 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível

Citações Citado por
10
Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies
Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies

SCHITTENHELM, Marcus M ; SHIRAGA, Sharon ; SCHROEDER, Arin ; CORBIN, Amie S ; GRIFFITH, Diana ; LEE, Francis Y ; BOKEMEYER, Carsten ; DEININGER, Michael W. N ; DRUKER, Brian J ; HEINRICH, Michael C

Cancer research (Chicago, Ill.), 2006, Vol.66 (1), p.473-481 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2002  (10)
  2. 2002Até2006  (20)
  3. 2007Até2011  (24)
  4. 2012Até2017  (16)
  5. Após 2017  (24)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (91)
  2. Japonês  (24)
  3. Alemão  (2)
  4. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.